This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation
September 16-17, 2025
Hynes Convention CenterBoston, US

Anton Pekcec
Director CardioRenalMetabolic Diseases Research/ Head of Obesity Research & Muscle Health at Boehringer Ingleheim
Speaker

Agenda Sessions

  • Keynote Panel: Crafting Industry Collaborations – The Pharma Perspective

    09:40
  • Survodutide: A novel GCGR/GLP-1R Dual Peptide Agonist

    11:00